Job Description
The European Molecular Biology Laboratory (EMBL) is one of the highest ranked scientific research organisations in the world. The Headquarters Laboratory is located in Heidelberg (Germany), with additional sites in Barcelona (Spain), Grenoble (France), Hamburg (Germany), Hinxton near Cambridge (UK), Rome (Italy). We are seeking to recruit an outstanding postdoctoral fellow to work at the interface of high-throughput screening (HTS), chemical genomics and proteomics, with the aim to identify novel combinatorial drug treatments against bacterial intracellular pathogens of the Shigella genus, and dissect their mode-of-action (MoA) and resistance trajectories.
This post-doctoral position is a joint appointment at EMBL and with our industry partner GlaxoSmithKline (GSK). The successful candidate will join the
group of Dr. Nassos Typas, and work in close collaboration with Dr. Lluis Ballel-Pages and Dr. Elena Fernández-Álvaro (GSK- Tres Cantos) and their teams, as well as
Dr. Savitski’s team (EMBL). The candidate will be part of the EMBL Postdoctoral Program with access to training, mentorship and career development opportunities. In addition, he/she will also benefit from participation in the GSK post-doctoral program, formal mentorship and various trainings/seminar series in drug discovery. EMBL is a leading international research organization with a collaborative and interdisciplinary atmosphere (see
www.embl.de).
The successful candidate will work with a suite of cutting-edge technologies developed at the four labs, and will benefit from the highly interdisciplinary environment at EMBL and the Open Lab. Please contact Nassos Typas regarding further information.
Qualifications and Experience
The ideal candidate should have extensive experience in molecular biology and genetics. Experience in microbial genetics, genome-wide approaches, computational biology, high-throughput screening and infection biology are also preferred. Excellent communication and organizational skills and desire to work in a dynamic, interdisciplinary environment are essential.
Applicants should send their CV summarizing qualifications and experience, including the names and addresses of two referees, no later than 14th January 2018.
Application Instructions
Please apply online through
www.embl.org/jobs
Additional Information
About EMBL: The EMBL is Europe’s premier flagship institute in the Life Sciences (ranking in the top 10 worldwide), with additional sites in Barcelona (Spain), Grenoble (France), Hamburg (Germany), Hinxton (UK) and Rome (Italy). EMBL has a strong focus on cutting edge technologies. Major activities are in the areas of imaging and structural methods (high resolution light microscopy, cryo-EM, tissue imaging), genomics (quantitative genetics, chromatin and RNA biology, microbiome), proteomics, metabolomics, biosensors and microfluidics.
About GSK: GSK, a science-led global healthcare company, brings to collaborations a vast knowledge around target validation and cutting-edge Drug Discovery technologies (e.g. compound libraries, screening platforms, chemoinformatics, structural biology, chemical biology/chemoproteomics). GSK acquired the EMBL spinoff Cellzome in 2012 and thus maintains a presence on the EMBL campus.
EMBL is an inclusive, equal opportunity employer offering attractive conditions and benefits appropriate to an international research organisation with a very collegial and family friendly working environment. The remuneration package comprise a competitive salary, a comprehensive pension scheme, medical, educational and other social benefits, as well as financial support for relocation and installation, including your family.
Please note that appointments on fixed term contracts can be renewed, depending on circumstances at the time of the review.